Multicentric short term and safety study of ineffective esophageal motility patients treated with RefluxStop device.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
04 Jul 2024
Historique:
received: 14 09 2023
accepted: 24 06 2024
medline: 5 7 2024
pubmed: 5 7 2024
entrez: 4 7 2024
Statut: epublish

Résumé

Gastroesophageal reflux disease (GERD) presents a general health problem with a variety of symptoms and an impairment of life quality. Conservative therapies do not offer sufficient symptom relief in up to 30% of patients. Patients who suffer from ineffective esophageal motility (IEM) and also GERD may exhibit symptoms ranging from mild to severe. In cases where surgical intervention becomes necessary for this diverse group of patients, it is important to consider the potential occurrence of postoperative dysphagia. RefluxStop is a new alternative anti-reflux surgery potentially reducing postoperative dysphagia rates. In this bicentric tertiary hospital observational study consecutive patients diagnosed with PPI refractory GERD and IEM that received RefluxStop implantation were included. A first safety and efficacy evaluation including clinical examination and GERD-HRQL questionnaire was conducted. 40 patients (25 male and 15 female) were included. 31 patients (77.5%) were on PPI at time of surgery, with mean acid exposure time of 8.14% ± 2.53. The median hospital stay was 3 days. Postoperative QoL improved significantly measured by GERD HRQL total score from 32.83 ± 5.08 to 6.6 ± 3.71 (p < 0.001). A 84% reduction of PPI usage (p < 0.001) was noted. 36 patients (90%) showed gone or improved symptoms and were satisfied at first follow-up. Two severe adverse events need mentioning: one postoperative slipping of the RefluxStop with need of immediate revisional operation on the first postoperative day (Clavien-Dindo Score 3b) and one device migration with no necessary further intervention. RefluxStop device implantation is safe and efficient in the short term follow up in patients with GERD and IEM. Further studies and longer follow-up are necessary to prove long-lasting positive effects.

Identifiants

pubmed: 38965324
doi: 10.1038/s41598-024-65751-5
pii: 10.1038/s41598-024-65751-5
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

15425

Informations de copyright

© 2024. The Author(s).

Références

Collaborators GBDG-oRD. The global, regional, and national burden of gastro–oesophageal reflux disease in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 5(6), 561–581 (2020).
doi: 10.1016/S2468-1253(19)30408-X
Nirwan, J. S. et al. Global prevalence and risk factors of gastro–oesophageal reflux disease (GORD): Systematic review with meta-analysis. Sci. Rep. 10(1), 5814 (2020).
doi: 10.1038/s41598-020-62795-1 pubmed: 32242117 pmcid: 7118109
Yadlapati, R. & DeLay, K. Proton pump inhibitor-refractory gastroesophageal reflux disease. Med. Clin. N. Am. 103(1), 15–27 (2019).
doi: 10.1016/j.mcna.2018.08.002 pubmed: 30466671
Callahan, Z. M. et al. Outcomes after anti-reflux procedures: Nissen, Toupet, magnetic sphincter augmentation or anti-reflux mucosectomy?. Surg. Endosc. 37, 3944–3951 (2022).
doi: 10.1007/s00464-022-09544-9 pubmed: 35999311
Gyawali, C. P. et al. Ineffective esophageal motility: Concepts, future directions, and conclusions from the Stanford 2018 symposium. Neurogastroenterol. Motil. 31(9), e13584 (2019).
doi: 10.1111/nmo.13584 pubmed: 30974032 pmcid: 9380027
Yadlapati, R. et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0((c)). Neurogastroenterol. Motil. 33(1), 14058 (2021).
doi: 10.1111/nmo.14058
Abdel Jalil, A. A. & Castell, D. O. Ineffective esophageal motility (IEM): The old–new frontier in esophagology. Curr. Gastroenterol. Rep. 18(1), 1 (2016).
doi: 10.1007/s11894-015-0472-y pubmed: 26685862
Ho, S. C., Chang, C. S., Wu, C. Y. & Chen, G. H. Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease. Dig. Dis. Sci. 47(3), 652–656 (2002).
doi: 10.1023/A:1017992808762 pubmed: 11911355
Lee, K. J., Kim, J. H. & Cho, S. W. Prevalence of ineffective esophageal motility and its relevance to symptoms and esophageal acid exposure in Korean patients referred for foregut symptoms. Digestion 73, 171–177 (2006).
doi: 10.1159/000094525 pubmed: 16837802
Triadafilopoulos, G., Tandon, A., Shetler, K. P. & Clarke, J. Clinical and pH study characteristics in reflux patients with and without ineffective oesophageal motility (IEM). BMJ Open Gastroenterol. 3(1), e000126 (2016).
doi: 10.1136/bmjgast-2016-000126 pubmed: 28074151 pmcid: 5174815
Rangan, V. et al. Dysphagia worsens with increasing ineffective swallows among patients with ineffective esophageal motility. J. Clin. Gastroenterol. 57, 694–699 (2022).
doi: 10.1097/MCG.0000000000001738
Asti, E. et al. Removal of the magnetic sphincter augmentation device: Surgical technique and results of a single-center cohort study. Ann. Surg. 265(5), 941–945 (2017).
doi: 10.1097/SLA.0000000000001785 pubmed: 27163959
Skubleny, D. et al. LINX((R)) magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: A systematic review and meta-analysis. Surg. Endosc. 31(8), 3078–3084 (2017).
doi: 10.1007/s00464-016-5370-3 pubmed: 27981382
Reynolds, J. L. et al. Laparoscopic magnetic sphincter augmentation vs laparoscopic Nissen fundoplication: A matched-pair analysis of 100 patients. J. Am. Coll. Surg. 221(1), 123–128 (2015).
doi: 10.1016/j.jamcollsurg.2015.02.025 pubmed: 26095560
Bjelovic, M. et al. Non-active implantable device treating acid reflux with a new dynamic treatment approach: 1 year results : RefluxStop
doi: 10.1186/s12893-020-00794-9 pubmed: 32689979 pmcid: 7370422
Velanovich, V. The development of the GERD-HRQL symptom severity instrument. Dis. Esophagus 20(2), 130–134 (2007).
doi: 10.1111/j.1442-2050.2007.00658.x pubmed: 17439596
Stephan, D., Borbely, Y. & Schoppmann, S. F. RefluxStop
doi: 10.52198/22.STI.41.GS1622 pubmed: 36255718
Armstrong, D. et al. The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology 111(1), 85–92 (1996).
doi: 10.1053/gast.1996.v111.pm8698230 pubmed: 8698230
Gyawali, C. P. et al. Modern diagnosis of GERD: The Lyon consensus. Gut 67(7), 1351–1362 (2018).
doi: 10.1136/gutjnl-2017-314722 pubmed: 29437910
Zhang, R. et al. Effect of laparoscopic angle of His reconstruction in the treatment of patients with gastroesophageal reflux disease and hiatal hernia. Chin. Med. J. 135(14), 1750–1752 (2022).
doi: 10.1097/CM9.0000000000002211 pubmed: 35947076 pmcid: 9509176
Fuchs, K. H. et al. Severity of GERD and disease progression. Dis. Esophagus https://doi.org/10.1093/dote/doab006 (2021).
doi: 10.1093/dote/doab006 pubmed: 33575739
Herbella, F. A. & Del Grande, J. C. Human cadavers as an experimental model for esophageal surgery. Dis. Esophagus 14(3–4), 218–222 (2001).
doi: 10.1046/j.1442-2050.2001.00205.x pubmed: 11869323
Nissen, R. Gastropexy as the lone procedure in the surgical repair of hiatus hernia. Am. J. Surg. 92(3), 389–392 (1956).
doi: 10.1016/S0002-9610(56)80111-6 pubmed: 13354861
Herbella, F. A., Oliveira, D. R. & Del Grande, J. C. Eponyms in esophageal surgery. Dis. Esophagus 17(1), 1–9 (2004).
doi: 10.1111/j.1442-2050.2004.00346.x pubmed: 15209735
Stylopoulos, N. & Rattner, D. W. The history of hiatal hernia surgery: From Bowditch to laparoscopy. Ann. Surg. 241(1), 185–193 (2005).
doi: 10.1097/01.sla.0000149430.83220.7f pubmed: 15622007 pmcid: 1356862
Nguyen, N. T. T. N. et al. The American Foregut Society white paper on the endoscopic classification of esophagogastric junction integrity. Foregut 2(4), 339–348 (2022).
doi: 10.1177/26345161221126961
Hasak, S., Brunt, L. M., Wang, D. & Gyawali, C. P. Clinical characteristics and outcomes of patients with postfundoplication dysphagia. Clin. Gastroenterol. Hepatol. 17(10), 1982–1990 (2019).
doi: 10.1016/j.cgh.2018.10.020 pubmed: 30342262
Fringeli, Y., Linas, I., Kessler, U. & Zehetner, J. Short-term results of laparoscopic anti-reflux surgery with the RefluxStop device in patients with gastro-esophageal reflux disease and ineffective esophageal motility. Langenbecks Arch. Surg. 409(1), 78 (2024).
doi: 10.1007/s00423-024-03264-5 pubmed: 38418718 pmcid: 10901965

Auteurs

J Feka (J)

Department of Surgery, Division of General Surgery, Comprehensive Cancer Center, Upper-GI Unit, Medical University of Vienna, Spitalgasse 23, Waehringer Guertel 18-20, 1090, Vienna, Austria.

M Saad (M)

Department of Surgery, Division of General Surgery, Comprehensive Cancer Center, Upper-GI Unit, Medical University of Vienna, Spitalgasse 23, Waehringer Guertel 18-20, 1090, Vienna, Austria.

N Boyle (N)

Department of Surgery, King Edward VII's Hospital, London, UK.

M Paireder (M)

Department of Surgery, Division of General Surgery, Comprehensive Cancer Center, Upper-GI Unit, Medical University of Vienna, Spitalgasse 23, Waehringer Guertel 18-20, 1090, Vienna, Austria.

I Kristo (I)

Department of Surgery, Division of General Surgery, Comprehensive Cancer Center, Upper-GI Unit, Medical University of Vienna, Spitalgasse 23, Waehringer Guertel 18-20, 1090, Vienna, Austria.

E Rieder (E)

Department of Surgery, Division of General Surgery, Comprehensive Cancer Center, Upper-GI Unit, Medical University of Vienna, Spitalgasse 23, Waehringer Guertel 18-20, 1090, Vienna, Austria.

R Asari (R)

Department of Surgery, Division of General Surgery, Comprehensive Cancer Center, Upper-GI Unit, Medical University of Vienna, Spitalgasse 23, Waehringer Guertel 18-20, 1090, Vienna, Austria.

S F Schoppmann (SF)

Department of Surgery, Division of General Surgery, Comprehensive Cancer Center, Upper-GI Unit, Medical University of Vienna, Spitalgasse 23, Waehringer Guertel 18-20, 1090, Vienna, Austria. Sebastian.schoppmann@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH